The landscape of dementia analysis has developed drastically with the appearance of advanced biomarkers, together with amyloid PET scans, tau imaging, and blood-primarily based assessments which can detect Alzheimer's pathology many years ahead of symptoms emerge. Even though these technological innovations signify impressive progress in comprehens